Post-approval studies (Phase 4)Study completedNCT01214434What this trial is testingPromiseb Topical Cream for Cradle CapWho this might be right forCradle CapInfantile Seborrheic Dermatitis Promius Pharma, LLC 42
Large-scale testing (Phase 3)Study completedNCT02013037What this trial is testingThe De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac TransplantationWho this might be right forAntibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more Cedars-Sinai Medical Center 36
Not applicableStudy completedNCT02425930What this trial is testingThe Predictive Value of Complement C3 in Patients With Advanced Gastric CancerWho this might be right forGastric CancerComplement Component DeficiencySurgery First Affiliated Hospital, Sun Yat-Sen University 85
Testing effectiveness (Phase 2)Looking for participantsNCT06419205What this trial is testingEvaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GWho this might be right forIgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy Akebia Therapeutics 30
Not applicableEnrolling By InvitationNCT07292493What this trial is testingImmune System in Diabetic Kidney DiseaseWho this might be right forDiabetesDiabetic Kidney DiseaseComplement System University Medical Centre Ljubljana 90